Self-management of oxygen and bronchodilators to relieve the dyspnoea of lung cancer with pneumoconiosis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Kim JW;Kim JW; Park EY; Park EY
  • Source:
    International journal of palliative nursing [Int J Palliat Nurs] 2020 Apr 02; Vol. 26 (4), pp. 167-174.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: MA Healthcare Country of Publication: England NLM ID: 9506762 Publication Model: Print Cited Medium: Internet ISSN: 2052-286X (Electronic) Linking ISSN: 13576321 NLM ISO Abbreviation: Int J Palliat Nurs
    • Publication Information:
      Publication: London : MA Healthcare
      Original Publication: London : Mark Allen Pub., c1995-
    • Subject Terms:
      Self-Management*; Bronchodilator Agents/*therapeutic use ; Dyspnea/*therapy ; Lung Neoplasms/*therapy ; Oxygen Inhalation Therapy/*methods ; Pneumoconiosis/*therapy; Activities of Daily Living ; Aged ; Aged, 80 and over ; Dyspnea/etiology ; Female ; Humans ; Lung Neoplasms/complications ; Male ; Middle Aged ; Pneumoconiosis/complications
    • Abstract:
      Objective: This study aimed to evaluate the level of dyspnoea and the self-management strategies used to alleviate dyspnoea in lung cancer patients with concurrent pneumoconiosis, particularly oxygen therapy and bronchodilator treatment. Furthermore, the authors aimed to determine the factors associated with such self-management and to provide a basis for developing an applicable and safe treatment plan for alleviating dyspnoea.
      Method: This study involved a cross-sectional survey. Data were collected using self-report questionnaires from 79 participants between January and July 2016, and self-management strategies were analysed using analysis of variance and multiple logistic regression analysis.
      Results: In terms of the self-management practices employed to relieve dyspnoea, 53.2% of the patients adjusted their oxygen intake and 70.9% used bronchodilators over the prescribed dosage. Adjusting the oxygen intake was not significantly associated with any of the patient characteristics. The factors related to increased bronchodilator use were the presence of comorbidities, cardiopulmonary function, subjective respiratory distress, activities of daily living, and the number of prescribed bronchodilators.
      Conclusion: Dyspnoea is a severe critical condition, and urgent management of its clinical symptoms is required. Healthcare professionals who care for patients with lung cancer with pneumoconiosis should pay attention to the dyspnoea and manage it based on clinical evidence. Development of customised, integrated nursing treatment plans is needed to alleviate dyspnoea in patients with complications and chronic dyspnoea who have low daily activity levels.
    • Contributed Indexing:
      Keywords: Dyspnoea; Lung neoplasms; Pneumoconiosis; Self-management
    • Accession Number:
      0 (Bronchodilator Agents)
    • Publication Date:
      Date Created: 20200508 Date Completed: 20210531 Latest Revision: 20220414
    • Publication Date:
      20231215
    • Accession Number:
      10.12968/ijpn.2020.26.4.167
    • Accession Number:
      32378485